CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 114 filers reported holding CHEMOCENTRYX INC in Q2 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $584,000 | -58.8% | 11,400 | -50.2% | 0.00% | -50.0% |
Q4 2020 | $1,417,000 | +31.3% | 22,885 | +16.2% | 0.01% | +20.0% |
Q3 2020 | $1,079,000 | +20.7% | 19,695 | +26.8% | 0.01% | +25.0% |
Q2 2020 | $894,000 | +41.9% | 15,535 | -1.0% | 0.00% | 0.0% |
Q1 2020 | $630,000 | +4.7% | 15,685 | +3.1% | 0.00% | +33.3% |
Q4 2019 | $602,000 | +173.6% | 15,215 | -35.8% | 0.00% | +200.0% |
Q2 2019 | $220,000 | -27.2% | 23,692 | +8.8% | 0.00% | -50.0% |
Q1 2019 | $302,000 | +45.2% | 21,772 | +14.4% | 0.00% | +100.0% |
Q4 2018 | $208,000 | -31.4% | 19,032 | -20.5% | 0.00% | -50.0% |
Q3 2018 | $303,000 | -3.8% | 23,932 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $315,000 | -41.7% | 23,932 | -73.6% | 0.00% | -33.3% |
Q4 2017 | $540,000 | +30.4% | 90,684 | +62.6% | 0.00% | +50.0% |
Q3 2017 | $414,000 | – | 55,780 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |